Core Insights - RemeGen Co., Ltd. has received clearance from the FDA for its IND application for phase II clinical trials of its bispecific antibody RC148 in the US [1][2] - RC148 targets PD-1 and VEGF and is developed using RemeGen's bispecific antibody technology platform [2] - The FDA clearance is a significant milestone that is expected to expedite the global development process of RC148 [2] Company Developments - RemeGen is currently conducting clinical trials of RC148 as both a monotherapy and in combination therapy for advanced solid tumors in China [2] - The successful IND application clearance marks an important step in RemeGen's strategy to expand its presence in the global oncology market [1][2]

Core Insights - Exxon Mobil reported better-than-expected earnings for its second quarter, benefiting from robust prices for its petroleum products despite a sequential decline [1] Financial Performance - The strong results in the company's production business were attributed to favorable pricing conditions in the petroleum market [1]

Core Viewpoint - Defiance ETFs has launched the Defiance Enhanced Long Vol ETF (VIXI), which aims to provide enhanced total returns by combining long exposure to VIX futures with leveraged short exposure to the S&P 500 Index, targeting periods of high volatility and declining equity markets [1][2]. Group 1: Fund Strategy - VIXI offers active investors a method to gain targeted exposure to market volatility while hedging against downturns in U.S. equities by pairing long VIX futures with a leveraged short position on the S&P 500 [2]. - The fund's long position in VIX futures is designed to capitalize on spikes in volatility, while its leveraged short exposure to the S&P 500 aims to enhance downside protection during equity sell-offs, leveraging the historically inverse relationship between equity markets and volatility [3]. Group 2: Company Background - Defiance, founded in 2018, is recognized for its innovation in the ETF space, specializing in thematic, leveraged, and volatility-based ETFs, including first-mover leveraged single-stock ETFs that allow investors to pursue amplified positions in high-growth companies [6].

Group 1 - Compugen (CGEN) is preparing for several catalysts in the coming years, focusing on the development of its anti-PVRIG antibody COM701, which is currently under exploration [2] - The company is part of the Biotech Analysis Central service, which provides in-depth analysis of various pharmaceutical companies and includes a model portfolio of small and mid-cap stocks [2] Group 2 - The Biotech Analysis Central service offers a library of over 600 biotech investing articles and live chat features to assist healthcare investors in making informed decisions [2]

Core Viewpoint - MINISO Group Holding Limited plans to release its financial results for the June quarter and interim period of 2025 on August 21, 2025, before the U.S. market opens [1]. Group 1: Financial Results Announcement - The earnings conference call will take place at 5:00 A.M. Eastern Time on August 21, 2025, with simultaneous interpretation in English [2]. - Access to the conference call can be made via a Zoom link or by dialing specific phone numbers [3][4]. - A replay of the conference call will be available approximately two hours after the live event on the Company's investor relations website [5]. Group 2: Company Overview - MINISO Group is a global value retailer known for offering trendy lifestyle products with IP design, aiming to provide a delightful shopping experience [6]. - The Company has established a significant store network worldwide since its first store opened in China in 2013, building the MINISO brand as a globally recognized retail name [6].

Group 1 - The Vita Coco Company (NASDAQ: COCO) previously received a neutral rating due to concerns over tariff situations that could impact consensus estimates [1] - The company's 2Q25 results were strong, particularly in the core coconut water segment [1] - The investment approach focuses on identifying undervalued companies with long-term growth potential, emphasizing value investing principles [1]

Group 1 - The investor has a contrarian investment style, focusing on high-risk, illiquid options and shares, with a portfolio split of approximately 50%-50% [1] - The investment strategy involves buying stocks that have recently experienced sell-offs due to non-recurrent events, especially when insiders are purchasing shares at lower prices [1] - Fundamental analysis is employed to assess the health of companies, their leverage, and to compare financial ratios with sector and industry averages [1] Group 2 - Technical analysis is utilized to optimize entry and exit points, primarily using multicolor lines for support and resistance levels on weekly charts [1] - The investor conducts professional background checks on insiders who purchase shares after sell-offs to ensure credibility [1] - The investment timeframe typically ranges from 3 to 24 months, indicating a medium-term investment horizon [1]

Group 1 - Jyske Realkredit plans to conduct auctions for refinancing on August 26 and 27, 2025, for loans in cover pool E, with a total refinancing amount of 3,600 million DKK for each day [1][4] - The auction will be held on Bloomberg's auction system, with bids required to be in multiples of 1,000,000 DKK and specific decimal accuracy depending on the bond maturity [4][5] - All auctioned bonds are rated AAA by S&P, indicating a high credit quality [8] Group 2 - The value date for all trades executed at the auction will be October 1, 2025, and the bonds will be subject to long settlement [6] - Jyske Realkredit offers a reverse facility for auction participants who need the bonds sooner, allowing them to sell allotted bonds with a repurchase agreement for the value date of October 1, 2025 [7][8] - The company reserves the right to change or postpone the offering based on loan disbursements during the auction period, with notifications to be made if a sale must be canceled [10][11]

Core Viewpoint - The company Net Lease Office Properties (NLOP) is projected to achieve "net debt zero" and commence distributions in 2025, as previously forecasted in an update published in January [1]. Group 1 - NLOP is the largest position for the author, indicating significant confidence in its future performance [1]. - The forecast made in January regarding NLOP's financial status and distribution plans has been confirmed as the target date approaches [1].

Group 1 - Baltic Horizon Fund is hosting an investor conference webinar on 15 August 2025 at 13:00 PM (CET) or 14:00 PM (EET) [1] - The webinar will be led by Tarmo Karotam, the Fund Manager, and will include a Q&A session [1] - Participants are encouraged to submit questions by 14 August to facilitate the Q&A [1] Group 2 - Registration for the webinar is available until 15 August at 12:00 PM (CET)/ 13:00 PM (EET) [2] - First-time attendees will need to download a plug-in, which is a quick process [2] - A reminder email will be sent to registered participants one hour before the webinar [3] Group 3 - The webinar will be recorded and made available on the company's website and YouTube account [3] - For further inquiries, Tarmo Karotam can be contacted via email [4] - Baltic Horizon Fund is a registered contractual public closed-end real estate fund managed by Northern Horizon Capital AS [4]